Delivery of the gene encoding the tumor suppressor Sef into prostate tumors by therapeutic-ultrasound inhibits both tumor angiogenesis and growth
Abstract Carcinomas constitute over 80% of all human cancer types with no effective therapy for metastatic disease. Here, we demonstrate, for the first time, the efficacy of therapeutic-ultrasound (TUS) to deliver a human tumor suppressor gene, hSef-b, to prostate tumors in vivo. Sef is downregulate...
Guardado en:
Autores principales: | Sabrin Mishel, Boris Shneyer, Lina Korsensky, Orit Goldshmidt-Tran, Tom Haber, Marcelle Machluf, Dina Ron |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/18777b20c254425b9579b5a09b321728 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multiscale modeling of tumor growth and angiogenesis: Evaluation of tumor-targeted therapy.
por: Sahar Jafari Nivlouei, et al.
Publicado: (2021) -
Inhibition of MYC by the SMARCB1 tumor suppressor
por: April M. Weissmiller, et al.
Publicado: (2019) -
Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth
por: Huan Liu, et al.
Publicado: (2020) -
Discovery of a small protein-encoding cis-regulatory overlapping gene of the tumor suppressor gene Scribble in humans
por: Yuhta Nomura, et al.
Publicado: (2021) -
Regulatory Role of microRNAs in Tumor Angiogenesis
por: Popov T., et al.
Publicado: (2020)